COM:TWISTBIOSCIENCE
Twist Bioscience
- Stock
Last Close
41.66
22/11 21:00
Market Cap
2.97B
Beta: -
Volume Today
716.37K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | ||
---|---|---|---|---|---|---|---|---|---|
net income | -44.09M - | -59.31M 34.53% | -71.24M 20.11% | -107.67M 51.14% | -139.93M 29.96% | -152.10M 8.69% | -217.86M 43.24% | -204.62M 6.08% | |
depreciation and amortization | 4.23M - | 5.02M 18.73% | 5.73M 14.06% | 6.11M 6.71% | 6.68M 9.26% | 9.75M 46.02% | 16.51M 69.37% | 29.31M 77.49% | |
deferred income tax | -68K - | 768K 1,229.41% | 42K 94.53% | -1.06M 2,623.81% | -214K 79.81% | 630K 394.39% | -410K - | ||
stock based compensation | 857K - | 1.89M 120.65% | 2.96M 56.58% | 11.17M 277.24% | 17.10M 53.05% | 37.00M 116.41% | 79.66M 115.32% | 30.28M 61.99% | |
change in working capital | 240K - | -129K 153.75% | -4.22M 3,171.32% | 3.00M 171.00% | -25.18M 940.32% | -9.38M 62.74% | -5.36M 42.91% | -1.01M 81.16% | |
accounts receivables | -702K - | -1.62M 131.20% | -3.07M 89.34% | -6.68M 117.54% | -14.27M 113.49% | -2.20M 84.57% | -9.62M 336.97% | -4.32M 55.10% | |
inventory | -1.23M - | -599K 51.22% | -4.20M 601.50% | -1.30M 69.01% | -4.96M 280.65% | -19.49M 293.24% | -7.54M 61.33% | 7.24M 196.05% | |
accounts payables | 466K - | 560K 20.17% | 3.76M 571.25% | 3.28M 12.80% | -5.51M 267.97% | 8.54M 255.14% | 7.38M 13.57% | -2.51M 133.97% | |
other working capital | 1.70M - | 1.53M 10.04% | -704K 145.92% | 7.71M 1,194.46% | -442K 105.74% | 3.77M 952.49% | 4.42M 17.28% | -410K 109.28% | |
other non cash items | 238K - | 458K 92.44% | 562K 22.71% | 515K 8.36% | -707K 237.28% | 1.86M 362.66% | 2.66M 43.03% | 3.98M 49.66% | |
net cash provided by operating activities | -38.59M - | -51.30M 32.93% | -66.16M 28.97% | -87.94M 32.91% | -142.25M 61.77% | -112.24M 21.10% | -124.39M 10.82% | -142.47M 14.54% | |
investments in property plant and equipment | -6.23M - | -6.59M 5.86% | -3.69M 44.07% | -14.76M 300.14% | -9.87M 33.13% | -27.06M 174.23% | -101.86M 276.40% | -27.78M 72.73% | |
acquisitions net | 266K - | 17K 93.61% | 21K 23.53% | 104.78M 498,861.90% | -483K 100.46% | -8.16M 1,589.44% | 5.86M 171.81% | ||
purchases of investments | -27.29M - | -40.59M 48.72% | -3.52M 91.32% | -177.57M 4,940.42% | -202.88M 14.25% | -58.80M 71.02% | -217.64M 270.17% | -76.34M 64.92% | |
sales maturities of investments | 36.92M - | 34.50M 6.57% | 87.50M 153.62% | 98.10M 12.11% | 242.49M 147.19% | 100.48M 58.56% | 154.74M 54.00% | ||
other investing activites | 174K - | 120K 31.03% | -434K 461.67% | -104.78M - | -5.75M - | -5.86M 1.82% | |||
net cash used for investing activites | -33.34M - | -9.87M 70.40% | 26.87M 372.26% | -104.81M 490.03% | -114.65M 9.39% | 156.16M 236.20% | -232.93M 249.17% | 50.61M 121.73% | |
debt repayment | -426K - | -4.17M 879.58% | -2.50M - | -3.33M 33.32% | -3.33M 0% | -1.56M 53.26% | |||
common stock issued | 152K - | 205K 34.87% | 331K 61.46% | 156.21M 47,092.75% | 295.56M 89.21% | 323.86M 9.57% | 269.82M 16.69% | 5.32M 98.03% | |
common stock repurchased | -2.42M - | -10.85M 348.12% | -7.75M 28.53% | -4.41M 43.19% | |||||
dividends paid | |||||||||
other financing activites | 69.92M - | 67.77M 3.08% | 88.49M 30.58% | 4.87M 94.50% | 13.92M 185.89% | 19.50M 40.08% | 10.02M 48.60% | ||
net cash used provided by financing activities | 69.65M - | 63.80M 8.39% | 88.82M 39.22% | 158.58M 78.53% | 303.73M 91.53% | 329.18M 8.38% | 270.53M 17.82% | 911K 99.66% | |
effect of forex changes on cash | 30K - | 21K 30% | 20K 4.76% | -319K 1,695% | -27K 91.54% | ||||
net change in cash | -2.29M - | 2.63M 214.94% | 49.53M 1,782.55% | -34.14M 168.93% | 46.85M 237.23% | 373.11M 696.43% | -87.10M 123.34% | -90.98M 4.45% | |
cash at beginning of period | 30.89M - | 28.60M 7.41% | 31.23M 9.20% | 81.54M 161.11% | 47.40M 41.87% | 94.25M 98.84% | 467.36M 395.89% | 380.26M 18.64% | |
cash at end of period | 28.60M - | 31.23M 9.20% | 80.76M 158.61% | 47.40M 41.31% | 94.25M 98.84% | 467.36M 395.89% | 380.26M 18.64% | 289.28M 23.93% | |
operating cash flow | -38.59M - | -51.30M 32.93% | -66.16M 28.97% | -87.94M 32.91% | -142.25M 61.77% | -112.24M 21.10% | -124.39M 10.82% | -142.47M 14.54% | |
capital expenditure | -6.23M - | -6.59M 5.86% | -3.69M 44.07% | -14.76M 300.14% | -9.87M 33.13% | -27.06M 174.23% | -101.86M 276.40% | -27.78M 72.73% | |
free cash flow | -44.82M - | -57.90M 29.17% | -69.85M 20.65% | -102.69M 47.02% | -152.12M 48.13% | -139.31M 8.43% | -226.24M 62.41% | -170.25M 24.75% |
All numbers in (except ratios and percentages)